Literature DB >> 32162175

miR-497 plays a key role in Tanshinone IIA-attenuated proliferation in OCI-AML3 cells via the MAPK/ERK1/2 pathway.

Hongyang Kang1,2, Changqing Tong2, Chaonan Li1, Jianmin Luo3.   

Abstract

Acute myelod leukemia (AML), as a uncontrolled proliferation of cells, was arrested differentiation of progenitor cells. The present study aimed to explore Tanshinone IIA (TIIA) effects on OCI-AML3 and the involvement of the MAPK signaling pathway and miR-497 in TIIA-mediated effects. Cell growth percentage was detected using a cell counting kit. Expression of miR-497 was detected by qPCR. Phosphorylated ERK1/2, JNK and p38 were assessed using western blot. The growth percentage of OCI-AML3 decreased and the effected time increased with increasing TIIA concentration. The miR-497 was upregulated and the p-ERK1/2 was decreased when the TIIA added. TIIA cannot influence the p-ERK1/2. Hence, the proliferation of OCI-AML3 cells was raising. However, when the p-ERK1/2 was inhibited, there no influence on the miR-497 expression after TIIA added. TIIA upregulates miR-497, and decrease the p-ERK1/2 expression, when TIIA simulated OCI-AML3 cell in vitro. And in miR-497 might be involved in the regulation of proliferation in this process.

Entities:  

Keywords:  ANL; MAPK/ERK1/2; OCI-AML3; TIIA; miR-497

Year:  2020        PMID: 32162175      PMCID: PMC7225231          DOI: 10.1007/s10616-020-00389-5

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  23 in total

1.  [Effect of Quercetin on the Cell Cycle and Adhesion Molecules of NOD/SCID Mice with Acute B Lymphocytic Leukemia].

Authors:  Li Wang; Hong-Wei Dai; Jun Zheng; Jiao Zhou; De-Sen Chen
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2018-12

2.  Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway.

Authors:  X-Z Hao; H-M Fan
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-06       Impact factor: 3.507

3.  Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1α.

Authors:  Ju Yeon Kim; Jae-Jun Song; Byoung-Mog Kwon; Jong Dae Lee
Journal:  Mol Med Rep       Date:  2015-06-15       Impact factor: 2.952

4.  Quercetin inhibited murine leukemia WEHI-3 cells in vivo and promoted immune response.

Authors:  Chun-Shu Yu; Kuang-Chi Lai; Jai-Sing Yang; Jo-Hua Chiang; Chi-Cheng Lu; Chang-Lin Wu; Jing-Pin Lin; Ching-Lung Liao; Nou-Ying Tang; W Gibson Wood; Jing-Gung Chung
Journal:  Phytother Res       Date:  2010-02       Impact factor: 5.878

5.  Characterization of dual PTEN and p53-targeting microRNAs identifies microRNA-638/Dnm2 as a two-hit oncogenic locus.

Authors:  Yvonne Tay; Shen Mynn Tan; Florian A Karreth; Judy Lieberman; Pier Paolo Pandolfi
Journal:  Cell Rep       Date:  2014-07-31       Impact factor: 9.423

6.  Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Authors:  Lohith Bachegowda; Kerry Morrone; Shannon L Winski; Ioannis Mantzaris; Matthias Bartenstein; Nandini Ramachandra; Orsi Giricz; Vineeth Sukrithan; George Nwankwo; Samira Shahnaz; Tushar Bhagat; Sanchari Bhattacharyya; Amer Assal; Aditi Shastri; Shanisha Gordon-Mitchell; Andrea Pellagatti; Jacqueline Boultwood; Carolina Schinke; Yiting Yu; Chandan Guha; James Rizzi; Jennifer Garrus; Suzy Brown; Lance Wollenberg; Grant Hogeland; Dale Wright; Mark Munson; Mareli Rodriguez; Stefan Gross; David Chantry; Yiyu Zou; Leonidas Platanias; Laurence E Burgess; Kith Pradhan; Ulrich Steidl; Amit Verma
Journal:  Cancer Res       Date:  2016-06-10       Impact factor: 12.701

7.  The Hippo pathway acts via p53 and microRNAs to control proliferation and proapoptotic gene expression during tissue growth.

Authors:  Wei Zhang; Stephen M Cohen
Journal:  Biol Open       Date:  2013-06-20       Impact factor: 2.422

8.  miR-145 and miR-497 suppress TGF-β-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH.

Authors:  Qi Yin; Yang Han; Dongyi Zhu; Zhanxia Li; Shan Shan; Wenjing Jin; Qingchun Lu; Tao Ren
Journal:  Cancer Cell Int       Date:  2018-07-27       Impact factor: 5.722

9.  Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib.

Authors:  Teresa Faranda; Ilaria Grossi; Michele Manganelli; Eleonora Marchina; Gianluca Baiocchi; Nazario Portolani; Marialuisa Crosatti; Giuseppina De Petro; Alessandro Salvi
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

10.  Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.

Authors:  Lina Han; Qi Zhang; Monique Dail; Ce Shi; Antonio Cavazos; Vivian R Ruvolo; Yang Zhao; Eugene Kim; Mohamed Rahmani; Duncan H Mak; Sha S Jin; Jun Chen; Darren C Phillips; Paul Bottecelli Koller; Rodrigo Jacamo; Jared K Burks; Courtney DiNardo; Naval Daver; Elias Jabbour; Jing Wang; Hagop M Kantarjian; Michael Andreeff; Steven Grant; Joel D Leverson; Deepak Sampath; Marina Konopleva
Journal:  Haematologica       Date:  2019-05-23       Impact factor: 11.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.